Evidence map›Paper›PMID 35904886›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2022

The development of peripheral microvasculopathy with chronic metabolic disease in obese Zucker rats: a retrograde emergence?

Brayden D Halvorson, Nithin J Menon, Daniel Goldman, Stephanie J Frisbee, Adam G Goodwill, Joshua T Butcher, Phoebe A Stapleton, Steven D Brooks, Alexandre C d'Audiffret, Robert W Wiseman and 5 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Improving rigor and reproducibility in cardiovascular research.American journal of physiology. Heart and circulatory physiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Brayden D HalvorsonDepartment of Medical Biophysics, University of Western Ontario, London, Ontario, Canada.
Nithin J MenonDepartment of Medical Biophysics, University of Western Ontario, London, Ontario, Canada.
Daniel GoldmanDepartment of Medical Biophysics, University of Western Ontario, London, Ontario, Canada.
Stephanie J FrisbeeDepartment Pathology and Laboratory Medicine, University of Western Ontario, London, Ontario, Canada.
Adam G GoodwillDepartment of Integrative Medical Sciences, Northeastern Ohio Medical University, Rootstown, Ohio.ORCID 0000-0003-3701-3713
Joshua T ButcherDepartment of Physiological Sciences, Oklahoma State University, Stillwater, Oklahoma.ORCID 0000-0002-7341-1949
Phoebe A StapletonDepartment of Pharmacology and Toxicology, Rutgers University, Piscataway, New Jersey.
Steven D BrooksLaboratory of Malaria and Vector Research, Physiology Unit, National Institute of Allergy and Infectious Diseases, Rockville, Maryland.ORCID 0000-0001-7357-1419
Alexandre C d'AudiffretDepartment of Cardiovascular and Thoracic Surgery, Rush Medical College, Chicago, Illinois.
Robert W WisemanDepartment of Physiology, Michigan State University, East Lansing, Michigan.
Julian H LombardDepartment of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Robert W BrockDepartment of Physiology and Pharmacology, West Virginia University, Morgantown, West Virginia.
I Mark OlfertDepartment of Physiology and Pharmacology, West Virginia University, Morgantown, West Virginia.ORCID 0000-0003-3505-9945
Paul D ChantlerDivision of Exercise Physiology, West Virginia University, Morgantown, West Virginia.ORCID 0000-0001-6960-9728
Jefferson C FrisbeeDepartment of Medical Biophysics, University of Western Ontario, London, Ontario, Canada.ORCID 0000-0003-2751-0599
Western University · CAWest Virginia University · USMedical College of Wisconsin · USMichigan State University · USNational Institute of Allergy and Infectious Diseases · USNortheast Ohio Medical University · USOklahoma State University · USRutgers, The State University of New Jersey · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
HIGH SALT DIET, ANGIOTENSIN II, AND MICROVESSEL DILATIONR01HL065289 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2000 to 2012
$3.8M
Central noradrenergic mechanisms of cerebrovascular pathology in Alzheimer's diseaseR01AG060731 · NIA · MICHIGAN STATE UNIVERSITY · PI COUNTS, SCOTT E · 2019 to 2023
$2.4M
Role of Nrf2 in Vascular Antioxidant DefenseR01HL128242 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2016 to 2019
$1.8M
Skeletal Muscle Microcirculation in Obese Zucker RatsR01DK064668 · NIDDK · WEST VIRGINIA UNIVERSITY · PI FRISBEE, JEFFERSON C · 2004 to 2009
$1.1M
Skeletal Muscle as a Target for Cardio-Metabolic Disease in Sarcopenic ObesityK01AG064121 · NIA · OKLAHOMA STATE UNIVERSITY STILLWATER · PI BUTCHER, JOSHUA THOMAS · 2020 to 2024
$644k
High Salt Diet, Angiotensin II, and Microvessel DilationR56HL065289 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBARD, JULIAN H · 2014 to 2014
$383k
NHLBI NIH HHS R01 HL065289NHLBI NIH HHS R01 HL128242NHLBI NIH HHS R56 HL065289NIA NIH HHS K01 AG064121NIA NIH HHS R01 AG060731NIDDK NIH HHS R01 DK064668NIEHS NIH HHS P30 ES005022
6 · The paper itself

Abstract

The study of peripheral vasculopathy with chronic metabolic disease is challenged by divergent contributions from spatial (the level of resolution or specific tissue being studied) and temporal origins (evolution of the developing impairments in time). Over many years of studying the development of skeletal muscle vasculopathy and its functional implications, we may be at the point of presenting an integrated conceptual model that addresses these challenges within the obese Zucker rat (OZR) model. At the early stages of metabolic disease, where systemic markers of elevated cardiovascular disease risk are present, the only evidence of vascular dysfunction is at postcapillary and collecting venules, where leukocyte adhesion/rolling is elevated with impaired venular endothelial function. As metabolic disease severity and duration increases, reduced microvessel density becomes evident as well as increased variability in microvascular hematocrit. Subsequently, hemodynamic impairments to distal arteriolar networks emerge, manifesting as increasing perfusion heterogeneity and impaired arteriolar reactivity. This retrograde "wave of dysfunction" continues, creating a condition wherein deficiencies to the distal arteriolar, capillary, and venular microcirculation stabilize and impairments to proximal arteriolar reactivity, wall mechanics, and perfusion distribution evolve. This proximal arteriolar dysfunction parallels increasing failure in fatigue resistance, hyperemic responses, and O

Indexed as

Metabolic DiseasesMetabolic SyndromePeripheral Vascular DiseasesAnimalsMicrocirculationMuscle, SkeletalObesityRatsRats, Zuckermicrocirculationmicrovascular systemsperipheral vascular diseaserat models of metabolic syndromeskeletal muscle fatigue

Identifiers

PMID35904886
PMCPMC9448278
OpenAlexW4288708357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.